with Durable Medical Equipment Supply Company · DME, Durable Medical Equipment Supply Company
LenderHawk analysis. Not affiliated with or endorsed by Acquisitions Anonymous.
A DME business can look cheap on headline EBITDA while still being fragile if insurers control both pricing and payment timing.
Audit risk matters as much as current earnings because payers can revisit old claims and demand documentation or claw back money.
The order of insurance coverage can materially change economics when a secondary payer cannot lift reimbursement above the primary payer’s rate.
Asset purchases may protect against past billing exposure but can also break payer contracts that a buyer needs to operate.
A business with a professional specialist on staff can still be under-resourced if the stated EBITDA must also support five employees in New Jersey.
COVID-era demand can temporarily inflate healthcare supply economics just when oversight and recoupment pressure is moving back up.
A business that depends on doctors, insurers, manufacturers, and patients all saying yes is structurally hard to control.
When one buyer or a small set of buyers controls reimbursement, the seller loses pricing power even if demand for the product is strong. The hosts use this lens to explain why insurers, not the supplier, capture the economics.
When to use: Use it when evaluating reimbursed healthcare supply businesses with concentrated payer power.
The listing asked $500,000 for a business with $491,000 in revenue and $125,000 in EBITDA, which works out to roughly 4x EBITDA.
The hosts summarize the BizQuest teaser economics.
The business had about $110,000 of inventory and $30,000 of FF&E included in the asking price.
They discuss what assets were being bundled into the sale.
The company had been operating for 15 years and served 2,400 total patients.
The listing description emphasizes longevity and patient base.
Rent was stated at $3,200 per month and the business employed five people.
The hosts assess overhead against the claimed earnings.
The listing was in Bergen County, New Jersey, and the seller said they were leaving for Florida.
The hosts treat the selling reason as a likely motivation for the ask.
The listing was originally posted on BizQuest and linked to a separate YouTube video about starting a medical supply business.
The hosts criticize the listing presentation and supplemental materials.
Insist on reviewing historical claims and documentation before buying a reimbursed medical supply business.
Why: Payers can audit prior billing and recoup money if paperwork is weak or incomplete.
Verify how primary and secondary insurance contracts are ordered for the patient base before you rely on projected reimbursement.
Why: The dominant payer can cap what the secondary payer will reimburse, which changes actual margins.
Treat asset-vs-stock structure as a deliberate tradeoff, not a formality.
Why: An asset deal may reduce legacy billing exposure but can jeopardize payer network continuity.
Stress-test payroll and specialist staffing against the actual EBITDA, not the listing headline.
Why: The stated profit looked too thin to support five employees and a professional orthotist in New Jersey.
Assume reimbursement-heavy healthcare supply businesses can deteriorate quickly if suppliers raise prices or insurers tighten allowed amounts.
Why: Margins are squeezed from both sides with very little room to pass costs through.
Michael uses Amazon’s delivery network as a comparison point: contractors can be given a business-in-a-box model where the platform sets the pay per package and the operator bears execution risk. The comparison is used to show how little leverage the DME seller has when a dominant buyer controls compensation.
Lesson: A business can be operationally busy yet economically powerless if one counterparty sets the economics.
The hosts compare Spirit Halloween’s ability to source branded costumes against smaller sellers who could not buy the same inventory cheaply enough to compete. The example reinforces that scale can create market access that smaller operators simply cannot replicate.
Lesson: When large buyers can source below your wholesale cost, scale becomes a moat and a threat at the same time.